Jeremy Rosenblum, MD
Associate Director, Solid Tumor Program
Undergraduate: Columbia University
Graduate: Albert Einstein College of Medicine
Residency: Children’s Hospital at Montefiore
Fellowship: Children’s Hospital at Montefiore
Pediatrics, Pediatric Hematology/Oncology
Areas of Interest and Expertise
Sarcomas, personalized cancer medicine
Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status. Rosenblum JM, Wijetunga NA, Fazzari MJ, Krailo M, Barkauskas DA, Gorlick R, Greally JM. Epigenetics. 2015 Jan 2;10(1):31-9.
Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negative. Rosenblum J, Lin J, Kim M, Levy AS. Pediatric Blood and Cancer. 2013 Jun;60(6):923-7.
Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma. Kubo T, Piperdi S, Rosenblum J, Antonescu CR, Chen W, Kim HS, Huvos AG, Sowers R, Meyers PA, Healey JH, Gorlick R. Cancer. 2008 May 15;112(10):2119-29.